Mjardin Group (MJARF) Stock Price, News & Analysis
Company Description
Mjardin Group (OTC Link: MJARF) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $9.0K.
MJARF has gained 0.0% over the past year. Shares last traded at $0.0000.
This page collects what Stock Titan holds for MJARF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Mjardin Group (MJARF) stock last traded at $0.0000. Over the past 12 months, the stock has gained 0.0%. At a market capitalization of $9.0K, MJARF is classified as a micro-cap stock with approximately 90.1M shares outstanding.
Latest News
Mjardin Group has 9 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 4 with negative movement. Key topics include management. View all MJARF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Mjardin Group (MJARF) currently stands at 23.0 thousand shares. With 1000.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Mjardin Group (MJARF) currently stands at 1000.0 days, up 83232.5% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 3085.7% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
MJARF Company Profile & Sector Positioning
Mjardin Group (MJARF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing MJARF often look at related companies in the same sector, including Priority Aviat (PJET), Item 9 Labs (INLB), Avivagen (VIVXF), Industry Source Consulting Inc (INSO), and Wowi (WOWU). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate MJARF's relative position within its industry.